Really Good News
Health 1 SOURCE · UNCORROBORATED ≈ENGLAND-WIDE; ABOUT 1,000 PATIENTS PER YEAR Sep 17, 2026

NHS England offers Enhertu to patients with HER2-low breast cancer

Doctors in England can now prescribe the drug Enhertu for patients with HER2-low incurable breast cancer. This access applies to about 1,000 patients per year. The drug extends life by an average of nearly seven months but is not a cure. This follows new guidance from NICE.

Why it matters

This provides a new option to extend life for patients with a form of incurable breast cancer.

Read the full reporting

Read at bbc.co.uk ↗

More in Health

Health
FDA Approves First Treatment for Sanfilippo Syndrome Type A
Health
NHS England agrees to cover Enhertu for HER2-low metastatic breast cancer
Health
Chile is validated by WHO as first South American country to eliminate dog-transmitted rabies in humans.
Health
Cambodia is the first country in Asia to meet a U.N. target for near-universal HIV diagnosis and treatment.

CHECKED · 1 SOURCE · UNCORROBORATED

← All news